Target intelligence / Profile preview

Amniotic membrane (AM)

Target
AM
Molecular classification
Other (tissue/biological scaffold)
01

Overview

The amniotic membrane is the innermost layer of the placenta and consists of a single epithelial cell layer, a thick basement membrane, and multiple stromal sublayers (compact, fibroblast, and spongy layers), containing types I, III, IV, V, and VII collagen, elastin, laminin, fibronectin, proteoglycans, as well as bioactive molecules (growth factors, cytokines)[1][2][4][5]. It is avascular and has remarkable mechanical stability and elasticity. Amniotic membrane naturally functions as a protective barrier for the fetus and regulates local inflammation, scarring, and tissue growth. Medically, it is used as a biological dressing or scaffold in ophthalmology, wound repair, and reconstructive surgery, valued for its immunomodulatory, anti-inflammatory, and regenerative properties[1][4][5][6][10]. It is not a drug target or discrete biomolecule; rather, it is a complex biological material applied for its physical and biochemical effects.

Other names
Amnionhuman amniotic membraneplacental membrane (amniotic portion)
02

Mechanism of action

Acts as a biological scaffold providing structural support[1][3][4] Delivers growth factors/cytokines for regeneration[2][6] Suppresses inflammation via release of anti-inflammatory factors[7] Reduces scarring by modulating fibroblast activity[5] Anti-microbial barrier[10]

03

Biological functions

Fetal protectionRegenerative capacityImmunomodulationAnti-inflammatory actionAnti-scarring/anti-fibrotic effectsAnti-microbial propertiesRegulation of wound healingPromotion of cell proliferation and differentiation
04

Disease associations

Used in ophthalmic diseases (burns, ulcers, non-healing wounds)Used in wound healing and reconstructive surgeryPotential role in inflammation controlTissue engineeringRegenerative medicine applications
05

Safety considerations

Disease transmission (if not properly processed)Possible immunogenic reactions (rare, mostly if cellular components remain)Variability in membrane properties between donorsEthics and regulations of tissue sourcing

Beyond the preview

Go deeper on Amniotic membrane (AM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amniotic membrane (AM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call